Abbott | ABT - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Abbott USD 5.86B 675M 2026-03
Agilent USD 990M 44M 2026-03
AtriCure USD 109.31M 3.97M 2026-03
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Bio-Rad Laboratories USD 345.2M 1.8M 2025-12
Boston Scientific USD 3.61B 64M 2026-03
Cooper Companies USD 735.4M 40.2M 2026-03
Danaher USD 3.59B 375M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Globus Medical USD 496.26M 39.69M 2026-03
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Medtronic USD 6.01B 595M 2026-03
Merit Medical Systems USD 184.8M 10.56M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Smith & Nephew USD 2.09B 117M 2025-12
Solventum Corp USD 1.1B 70M 2026-03
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.43M 21K 2026-03
Terumo JPY 149.02B 4.17B 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12